Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
57
APLS Quote, Financials, Valuation and Earnings
Last price:
$25.15
Seasonality move
:
7.92%
Day range:
$24.74 - $25.20
52-week range:
$16.10 - $35.57
Dividend yield:
0%
P/E ratio:
84.68x
P/S ratio:
3.13x
P/B ratio:
7.93x
Volume:
1.8M
Avg. volume:
2.4M
1-year change:
-24.49%
Market cap:
$3.2B
Revenue:
$781.4M
EPS (TTM):
$0.30
Earnings Data
Next earnings date for APLS
Feb 26
2026
Most recent earnings per share
$1.66
Beat by $0.72
(Oct 30/2025)
Consensus Estimate
$0.94
(Oct 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
APLS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $200.4M | -- | -- | -$0.38 | -- |
| 10/30/2025 | Q3 | $409.2M | $458.6M | $1.66 | $0.94 | $0.72 |
| 07/31/2025 | Q2 | $188.6M | $178.5M | -$0.33 | -$0.47 | $0.14 |
| 05/07/2025 | Q1 | $194.9M | $166.8M | -$0.74 | -$0.35 | -$0.39 |
| 02/28/2025 | Q4 | $197.9M | $212.5M | -$0.29 | -$0.41 | $0.12 |
| 11/05/2024 | Q3 | $199.8M | $196.8M | -$0.46 | -$0.27 | -$0.19 |
| 08/01/2024 | Q2 | $191.3M | $199.7M | -$0.30 | -$0.32 | $0.02 |
| 05/07/2024 | Q1 | $164.3M | $172.3M | -$0.54 | -$0.41 | -$0.13 |
| 02/27/2024 | Q4 | $143.6M | $146.4M | -$0.73 | -$0.70 | -$0.03 |
| 11/01/2023 | Q3 | -- | -- | -$1.17 | -$0.99 | -$0.18 |
| 07/31/2023 | Q2 | -- | -- | -$1.02 | -$1.34 | $0.32 |
| 05/04/2023 | Q1 | -- | -- | -$1.56 | -$1.46 | -$0.10 |
| 02/21/2023 | Q4 | -- | -- | -$1.50 | -$1.45 | -$0.05 |
| 11/07/2022 | Q3 | -- | -- | -$1.75 | -$1.43 | -$0.32 |
| 08/08/2022 | Q2 | -- | -- | -$1.46 | -$1.36 | -$0.10 |
| 05/04/2022 | Q1 | -- | -- | -$1.42 | -$1.19 | -$0.23 |
| 02/28/2022 | Q4 | -- | -- | -$1.53 | -$1.60 | $0.07 |
| 11/08/2021 | Q3 | -- | -- | -$2.28 | -$1.57 | -$0.71 |
| 08/09/2021 | Q2 | -- | -- | -$2.72 | -$1.66 | -$1.06 |
| 04/28/2021 | Q1 | -- | -- | -$2.32 | -$1.76 | -$0.56 |
| 02/25/2021 | Q4 | -- | -- | $1.06 | -$1.37 | $2.43 |
| 11/02/2020 | Q3 | -- | -- | -$1.79 | -$1.56 | -$0.23 |
| 07/31/2020 | Q2 | -- | -- | -$1.57 | -$1.35 | -$0.22 |
| 05/08/2020 | Q1 | -- | -- | -$2.29 | -$1.43 | -$0.86 |
| 02/27/2020 | Q4 | -- | -- | -$2.11 | -$1.16 | -$0.95 |
| 11/05/2019 | Q3 | -- | -- | -$1.10 | -$1.04 | -$0.06 |
| 07/31/2019 | Q2 | -- | -- | -$0.98 | -$0.74 | -$0.24 |
| 05/08/2019 | Q1 | -- | -- | -$0.84 | -$0.62 | -$0.22 |
| 02/26/2019 | Q4 | -- | -- | -$0.65 | -$0.68 | $0.03 |
| 11/13/2018 | Q3 | -- | -- | -$0.63 | -$0.69 | $0.06 |
| 07/31/2018 | Q2 | -- | -- | -$0.61 | -$0.42 | -$0.19 |
| 04/30/2018 | Q1 | -- | -- | -$0.43 | -$0.33 | -$0.10 |
| 03/19/2018 | Q4 | -- | -- | -$0.60 | -$0.48 | -$0.12 |
| 09/30/2017 | Q3 | -- | -- | -$0.23 | -$0.24 | $0.01 |
Apellis Pharmaceuticals, Inc. Earnings Questions
-
How Much did Apellis Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Apellis Pharmaceuticals, Inc. reported $458.6M worth of top line sales in its most recent quarter.
-
Did Apellis Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Apellis Pharmaceuticals, Inc. announced earnings per share of $1.66 which represents a beat of analyst forecast a $0.94 per share.
-
Is Apellis Pharmaceuticals, Inc. Profitable?
Apellis Pharmaceuticals, Inc. reported $433.7M that represents $3.33 per share over the last quarter.
-
What is the Analyst Consensus for Apellis Pharmaceuticals, Inc. EPS Next Year?
Apellis Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$1.60 per share to -$1.73 per share next year representing a decrease of -78.88%.
-
When is Apellis Pharmaceuticals, Inc.'s Earnings Date?
Apellis Pharmaceuticals, Inc.'s next earnings date is February 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
